NCT04892303View on ClinicalTrials.gov

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions
Recurrent Thyroid Cancer
Interventions
COMBINATION_PRODUCT

Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)

To safely administer a minimum cumulative dose of external beam radiation to up 3 index tumors per patient, supplemented radiation dose delivered by radioactive iodine (RAI)

Trial Locations (1)

21287

RECRUITING

The Johns Hopkins SKCCC, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER